Tag Archives: Regeneron Pharma

Despite hundreds of potential therapies for COVID-19 seeking to make their case, very few have crossed the finish line. One graduate candidate, Regeneron’s two-antibody cocktail, has earned early plaudits – and now a pharmaceutical giant is jumping on board to boost production in a big way. Regeneron will partner with …

Text size Sanofi is limiting its focus on drug development, stopping its diabetes and cardiovascular research. Joel Saget / AFP via Getty Images French pharmaceutical giant Sanofi is digging into the cash it raised earlier this year with the sale of its $ 11.7 billion stake in Regeneron Pharmaceuticals, the …